Researchers developed an ultrasensitive test detecting biomarkers for frontotemporal lobar degeneration (FTLD), a rare dementia form previously undiagnosable at the biomarker level.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Ultrasensitive test detects biomarkers for specific form of dementia
57 Million people People with dementia worldwide
Nearly Double in 20 years Projected dementia cases
Frontotemporal Lobar Degeneration (FTLD) rare dementia form Condition targeted
Doubles In 20 Years projected increase